Faculty of Medicine, University of Lund, Division of Neuroradiology, Department of Radiology, Malmö University Hospital, Malmö, Sweden.
Acta Neurol Scand. 2010 Aug;122(2):132-9. doi: 10.1111/j.1600-0404.2009.01277.x. Epub 2009 Oct 5.
To evaluate the association between the hyperdense middle cerebral artery sign (HMCAS) and the functional outcome on one hand, and different predictors such as the National Institutes of Health Stroke Scale (NIHSS), infarct size, ASPECTS Score, intracerebral hemorrhage, and mortality on the other hand.
Retrospective analysis of 120 patients with MCA-stroke treated with intravenous thrombolysis. We tested the association between HMCAS and NIHSS, infarct volume, ASPECTS, outcome, level of consciousness, different recorded time intervals, and the day/time of admission.
Seventy-four percentage of patients treated with thrombolysis developed cerebral infarction. All patients with HMCAS (n = 39) sustained infarction and only 31% showed favorable outcome compared with 62% and 60%, respectively among patients without HMCAS (P < 0.001 and P = 0.002). There was statistically significant association between functional outcome and HMCAS (P = 0.002), infarct volume, NIHSS, and ASPECTS (P < 0.001). The time to treatment was 12 min shorter in patients who developed infarction (P = 0.037). Independent predictors for outcome were NIHSS and the occurrence of cerebral infarction on computed tomography for the whole study population, and infarct volume for patients who sustained cerebral infarction.
Despite optimal workflow, patients with HMCAS showed poor outcome after intravenous thrombolysis. The results emphasize the urgent need for more effective revascularization therapies and neuroprotective treatment in this subgroup of stroke patients.
评估高密度大脑中动脉征(HMCAS)与功能预后之间的关系,以及与其他预测因素(如国立卫生研究院卒中量表[NIHSS]、梗死体积、ASPECTS 评分、颅内出血和死亡率)之间的关系。
对 120 例接受静脉溶栓治疗的 MCA 卒中患者进行回顾性分析。我们检验了 HMCAS 与 NIHSS、梗死体积、ASPECTS、预后、意识水平、不同记录时间间隔以及入院日/时之间的相关性。
74%接受溶栓治疗的患者发生脑梗死。所有 HMCAS 患者(n=39)均发生梗死,与无脑 HMCAS 患者(n=81)相比,仅 31%患者预后良好,而分别为 62%和 60%(P<0.001 和 P=0.002)。功能预后与 HMCAS(P=0.002)、梗死体积、NIHSS 和 ASPECTS 之间存在显著统计学相关性(P<0.001)。发生梗死的患者治疗时间缩短 12 分钟(P=0.037)。对于全研究人群,NIHSS 和 CT 上发生脑梗死是预后的独立预测因素,而对于发生脑梗死的患者,梗死体积是预后的独立预测因素。
尽管优化了工作流程,HMCAS 患者静脉溶栓后预后仍较差。这些结果强调了在这组卒中患者中急需更有效的血管再通治疗和神经保护治疗。